COVID-19 Information

Edit Entry | Edit CV

Anna N. A. Tosteson, ScD

Title(s):
Interim Director and Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology

Additional Titles/Positions/Affiliations:
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Norris Cotton Cancer Center
Associate Director, SYNERGY, Dartmouth's Clinical and Translational Science Institute

Department(s):
The Dartmouth Institute
Medicine
Community and Family Medicine

Education:
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS

Programs:
Norris Cotton Cancer Center
SYNERGY
The Dartmouth Institute for Health Policy and Clinical Practice

Contact Information:

Dartmouth Medical School
HB 7505
One Medical Center Drive
Lebanon NH 03756

Office: WTRB 526, DHMC
Phone: 603-653-3568
Email: Anna.Tosteson@dartmouth.edu

Assistant: Christopher Jacobs
Asst. Phone: 603-653-0802
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU


Professional Interests:

Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.

Grant Information:

Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )

Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)

Courses Taught:

PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis


Selected Publications:

 

Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling.
Alagoz O, Lowry KP, Kurian AW, Mandelblatt JS, Ergun MA, Huang H, Lee SJ, Schechter CB, Tosteson ANA, Miglioretti DL, Trentham-Dietz A, Nyante SJ, Kerlikowske K, Sprague BL, Stout NK
J Natl Cancer Inst. 2021 Jul 14; pii: djab097. doi: 10.1093/jnci/djab097. Epub 2021 Jul 14.
PMID: 34258611

Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium.
Sprague BL, O'Meara ES, Lee CI, Lee JM, Henderson LM, Buist DSM, Alsheik N, Macarol T, Perry H, Tosteson ANA, Onega T, Kerlikowske K, Miglioretti DL
Prev Med. 2021 Oct;151:106540. doi: 10.1016/j.ypmed.2021.106540. Epub 2021 Jun 30.
PMID: 34217424

Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study.
Schifferdecker KE, Vaclavik D, Wernli KJ, Buist DSM, Kerlikowske K, Sprague BL, Henderson LM, Johnson D, Budesky J, Jackson-Nefertiti G, Miglioretti DL, Tosteson ANA
Prev Med. 2021 Oct;151:106542. doi: 10.1016/j.ypmed.2021.106542. Epub 2021 Jun 30.
PMID: 34217409

The association between neurohormonal therapy and mortality in older adults with heart failure with reduced ejection fraction.
Gilstrap L, Austin AM, Gladders B, Goyal P, O'Malley AJ, Barnato A, Tosteson ANA, Skinner JS
J Am Geriatr Soc. 2021 Jun 15; doi: 10.1111/jgs.17310. Epub 2021 Jun 15.
PMID: 34129234

Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs.
Tosteson ANA, Tapp S, Titus LJ, Nelson HD, Longton GM, Bronson M, Pepe M, Carney PA, Onega T, Piepkorn MW, Knezevich SR, Barnhill R, Weinstock MA, Elder DE, Elmore JG
JAMA Dermatol. 2021 Jun 2; doi: 10.1001/jamadermatol.2021.1779. Epub 2021 Jun 2.
PMID: 34076664

Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.
Lee JM, Ichikawa LE, Wernli KJ, Bowles E, Specht JM, Kerlikowske K, Miglioretti DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM
Radiology. 2021 Aug;300(2):290-300. doi: 10.1148/radiol.2021204581. Epub 2021 May 18.
PMID: 34003059

Changes in Mammography Utilization by Women's Characteristics during the First 5 Months of the COVID-19 Pandemic.
Sprague BL, Lowry KP, Miglioretti DL, Alsheik N, Bowles EJA, Tosteson ANA, Rauscher G, Herschorn SD, Lee JM, Trentham-Dietz A, Weaver DL, Stout NK, Kerlikowske K
J Natl Cancer Inst. 2021 Mar 29; pii: djab045. doi: 10.1093/jnci/djab045. Epub 2021 Mar 29.
PMID: 33778894

Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, Onega T, O'Meara ES, Rauscher GH, Sprague BL, Tosteson ANA, Wernli KJ, Lee JM, Lee CI
JAMA Netw Open. 2021 Mar 1;4(3):e211974. doi: 10.1001/jamanetworkopen.2021.1974. Epub 2021 Mar 1.
PMID: 33764423

The Cost-Effectiveness of Reverse Total Shoulder Arthroplasty Versus Open Reduction Internal Fixation for Proximal Humerus Fractures in the Elderly.
Austin DC, Torchia MT, Tosteson ANA, Gitajn IL, Tapp SJ, Bell JE
Iowa Orthop J. 2020;40(2):20-29.
PMID: 33633504

Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status.
Lee CI, Zhu W, Onega T, Henderson LM, Kerlikowske K, Sprague BL, Rauscher GH, O'Meara ES, Tosteson ANA, Haas JS, diFlorio-Alexander R, Kaplan C, Miglioretti DL
JAMA Netw Open. 2021 Feb 1;4(2):e2037546. doi: 10.1001/jamanetworkopen.2020.37546. Epub 2021 Feb 1.
PMID: 33606032

View more publications on PubMed